Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney

Kidney International

Volumn 65, Issue 2, 2004, Pages 469-481

  Sasaki, Satoshi ^a   Nishihira, Jun ^b   Ishibashi, Teruo ^b   Yamasaki, Yoshiki ^b   Obikane, Katsuyuki ^b   Echigoya, Masayo ^b   Sado, Yoshikazu ^b   Ninomiya, Yoshifumi ^b   Kobayashi, Kunihiko ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Collagen type IV; Cytokine; Glomerulonephritis; Synaptopodin; Transgenic mice

Indexed keywords

BETA ACTIN; BETA GLOBIN; COLLAGEN TYPE 4; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CELL ACTIVITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE COURSE; ENHANCER REGION; EXTRACELLULAR MATRIX; GLOMERULOSA CELL; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FAILURE; MACROPHAGE; MACROPHAGE MIGRATION INHIBITION; MESANGIUM; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROGRESSIVE MESANGIAL SCLEROSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEINURIA; SCLEROSIS; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; UPREGULATION;

EID: 1642439082     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00394.x     Document Type: Article

References (53)

1. BLOOM BR, BENNET B: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82, 1966
2. DAVID JR: Delayed hypersensitivity in vitro: Its mediation by cell-free substrates formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56:72-77, 1966
3. POZZI LA, WEISER WY: Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell Immunol 145:372-379, 1992
4. WEISER WY, Pozzi LM, DAVID JR: Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. J Immunol 147:2006-2011, 1991
5. ONODERA S, SUZUKI K, MATSUNO T, et al: Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92:131-137, 1997
6. BERNHAGEN J, CALANDRA T, MITCHELL RA, et al: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759, 1993
7. BACHER M, METZ CN, CALANDRA T, et al: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849-7854, 1996
8. CALANDRA T, BERNHAGEN J, METZ CN, et al: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71, 1995
9. NISHIHIRA J: Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med 2:17-28, 1998
10. LAN HY, Mu W, YANG N, et al: De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 149:1119-1127, 1996
11. IMAMURA K, NISHIHIRA J, SUZUKI M, et al: Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney. Biochem Mol Biol Int 40:1233-1242, 1996
12. LAN HY, YANG N, NIKOLIC-PATERSON DJ, et al: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499-509, 2000
13. BROWN FG, NIKOLIC-PATERSON DJ, HILL PA, et al: Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 13(Suppl 1):S7-13, 2002
14. AKAGI Y, ISAKA Y, AKAGI A, et al: Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and β-actin/β-globin gene in glomerular epithelial cells in vivo. Kidney Int 51:1265-1269, 1997
15. AUSTYN JM, GORDON S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805-815, 1981
16. GUNTER KC, MALEK TR, SHEVACH EM: T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4. J Exp Med 159:716-730, 1984
17. MUNDEL P, HEID HW, MUNDEL TM, et al: Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139:193-204, 1997
18. KOBAYASHI S, NISHIHIRA J, WATANABE S, TODO S: Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 29:1752-1759, 1999
19. SADO Y, KAGAWA M, KISHIRO Y, et al: Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different α chains of human type IV collagen. Histochem Cell Biol 104:267-275, 1995
20. SAITO K, NAITO I, SEKI T, et al: Differential expression of mouse α5 (IV) and α6(IV) collagen genes in epithelial basement membranes. J Biochem (Tokyo) 128:427-434, 2000
21. MIYAZAKI J, TAKAKI S, ARAKI K, et al: Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 79:269-277, 1989
22. NIWA H, YAMAMURA K, MIYAZAKI J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199, 1991
23. NISHIHIRA J, KOYAMA Y, MIZUE Y: Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10:199-205, 1998
24. RAIJ L, AZAR S, KEANE W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143, 1984
25. OLSON JL, WILSON SK, HEPTINSTALL RH: Relation of glomerular injury to preglomerular resistance in experimental hypertension. Kidney Int 29:849-857, 1986
26. MIYATA T, NANGAKU M, SUZUKI D, et al: A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J Clin Invest 102:828-836, 1998
27. MITCHELL R, BACHER M, BERNHAGEN J, et al: Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154:3863-3870, 1995
28. SUZUKI D, MIYAZAKI M, JINDE K, et al: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52:111-119, 1997
29. MROWKA C, SCHEDL A: Wilms' tumor suppressor gene WT1: From structure to renal pathophysiologic features. J Am Soc Nephrol 11(Suppl 16):S106-115, 2000
30. KEMENY E, DURMULLER U, NICKELEIT V, et al: Distribution of podocyte protein (44 KD) in different types of glomerular diseases. Virchows Arch 431:425-430, 1997
31. SRIVASTAVA T, GAROLA RE, WHITING JM, ALON US: Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 59:118-125, 2001
32. LAN HY, YANG N, METZ C, et al: TNF-α up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3:136-144, 1997
33. LAN HY, BACHER M, YANG N, et al: The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185:1455-1465, 1997
34. TESCH GH, NIKOLIC-PATERSON DJ, METZ CN, et al: Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J Am Soc Nephrol 9:417-424, 1998
35. IMAI E, AKAGI Y, ISAKA Y, et al: Glowing podocytes in living mouse: Transgenic mouse carrying a podocyte-specific promoter. Exp Nephrol 7:63-66, 1999
36. NIKOLIC-PATERSON DJ, ATKINS RC: The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 16(Suppl 5):3-7, 2001
37. MOREL-MAROGER STRIKER L, KILLEN PD, CHI E, STRIKER GE: The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 51:181-192, 1984
38. DOI T, STRIKER LJ, KIMATA K, et al: Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 173:1287-1290, 1991
39. WIGGINS R, KERSHAW D, SMOYER W, HOLZMAN L: The glomerular podocyte, in Immunologic Renal Diseases, 2nd ed, edited by Neilson EG, Couser WG, Philadelphia, Lippincott Williams & Wilkins, 2001, pp 693-707
40. MUNDEL P, SHANKLAND SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13:3005-3015, 2002
41. MORIOKA Y, KOIKE H, IKEZUMI Y, et al: Podocyte injuries exacerbate mesangial proliferative glomerulonephritis. Kidney Int 60:2192-2204, 2001
42. HOSHI S, SHU Y, YOSHIDA F, et al: Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 82:25-35, 2002
43. BARISONI L, KRIZ W, MUNDEL P, D'AGATI: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51-61, 1999
44. NEALE TJ, RUGER BM, MACAULAY H, et al: Tumor necrosis factor-α is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 146:1444-1454, 1995
45. NIEMIR ZI, STEIN H, DWORACKI G, et al: Podocytes are the major source of IL-1 α and IL-1 β in human glomerulonephritides. Kidney Int 52:393-403, 1997
46. TORBOHM I, BERGER B, SCHONERMARK M, et al: Modulation of collagen synthesis in human glomerular epithelial cells by interleukin 1. Clin Exp Immunol 75:427-431, 1989
47. RICHARDSON CA, GORDON KL, COUSER WG, BOMSZTYK K: IL-1 β increases laminin B2 chain mRNA levels and activates NF-κ B in rat glomerular epithelial cells. Am J Physiol 268:F273-278, 1995
48. KOUKOURITAKI SB, VARDAKI EA, PAPAKONSTANTI EA, et al: TNF-α induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol Med 5:382-392, 1999
49. HUWILER A, REN S, HOLTHOFER H, et al: Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes. Biochem Biophys Res Commun 305:136-142, 2003
50. KLEEMANN R, HAUSSER A, GEIGER G, et al: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-216, 2000
51. BUCALA R: Signal transduction. A most interesting factor. Nature 408:146-147, 2000
52. BUDDE K, NEUMAYER HH, SALANT DJ, et al: Glomerular epithelial cell products stimulate mesangial cell proliferation in culture. Kidney Int 52:733-741, 1997
53. PAWLUCZYK IZ, HARRIS KP: Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells. Kidney Int 54:62-70, 1998